Czechia· CZ-0286073
KAVIGALE
A sipavibart product containing sipavibart, registered in Czechia by AstraZeneca AB, Södertälje. The same ATC class is registered in 7 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Sipavibart is registered in 7 of 19 countries.
Countries holding a registration under ATC J06BD09 (sipavibart), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 4 of them publish a price we can compare per daily dose
Sipavibart · ATC J06BD09
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
The record
At a glance
SÚKL (Czech Republic)- Active substance
- SIPAVIBART
- Manufacturer
- AstraZeneca AB, Södertälje
- Country
- Czechia (CZ)
- ATC code
- J06BD09
- ATC class
- Sipavibart
- Defined daily dose
- 0.3 g, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sipavibart in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumKavigale 300 mgAstraZeneca
- SpainKAVIGALE 300 MG SOLUCION INYECTABLE Y PARA PERFUSIONAstrazeneca Ab
- FinlandKAVIGALEAstraZeneca AB
- IcelandKavigaleAstraZeneca AB
- PolandKavigaleAstraZeneca AB
- SwedenKAVIGALE 300 mg Injektions-/infusionsvätska, lösningAstraZeneca AB
- IrelandKAVIGALE 300 mg solution for injection/infusionAstraZeneca AB
- NetherlandsKAVIGALE 300 mg oplossing voor injectie/infusieAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kavigale
- Liechtenstein · Kavigale
- Norway · Kavigale
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a3082db4-fc5e-454f-bc2c-5a0f79e11fc7 GET /v1/drugs/a3082db4-fc5e-454f-bc2c-5a0f79e11fc7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ/INF SOL",
"source": "sukl",
"strength": "300MG",
"pack_size": "1X2ML",
"substance": "SIPAVIBART",
"cz_kod_sukl": "0286073",
"product_type": "BT",
"substance_codes": "3155",
"registration_state": "R",
"registration_number": "EU/1/24/1900/001"
}See everything about sipavibart.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.